ReviewAnalytical and bioanalytical chemistry2025
Advances in carcinoembryonic antigen detection: a review of clinical applications and standardization.
Review in Analytical and bioanalytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Mn-Fe bimetallic oxide-mediated photothermal immunoassay for portable screening of carcinoembryonic antigen.Analytical and bioanalytical chemistry · 2026Article
- Article
- A sensitive and cost-effective "turn-on" aptasensor for carcinoembryonic antigen using Ce-UiO-66 as an ultraefficient nanoquencher.Mikrochimica acta · 2026Article
- Recent Advances in Graphene-Based Field-Effect Transistor Biosensors for Disease Biomarker Detection and Clinical Prospects.Biosensors · 2026Review
- Electrochemical Biosensors for Cancer Diagnosis and Prognosis Using Protein Biomarkers: Current Trends, Advances, and Clinical Translation Potential.Sensors (Basel, Switzerland) · 2026Review
- Label-free baseline-calibrated electrochemical immunosensor for carcinoembryonic antigen detection using electro-synthesized silver nanoparticles and citrate-capped NiFe₂O₄ nanoparticles on a glassy carbon electrode.Mikrochimica acta · 2026Article
- A high-affinity CEA-targeted nanobody forJournal of nanobiotechnology · 2025Article
- Fluorescent-Electrochemical-Colorimetric Triple-Model Immunoassays with Multifunctional Metal-Organic Frameworks for Signal Amplification.Biosensors · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Carcinoembryonic antigen (CEA) is among the earliest identified tumor markers and remains extensively utilized in the diagnosis and management of colorectal cancer. The detection of CEA presents considerable challenges in the field of analytical chemistry, given its complexity. The most prevalent detection approach is the immunoassay, including the chemiluminescence immunoassay commonly employed in clinical settings; however, discrepancies between various methods persist. Mass spectrometry-based techniques offer enhanced accuracy as they circumvent matrix interference. Nonetheless, the intricate nature of proteins continues to pose significant challenges. This paper reviews recent advancements in CEA detection technologies, examines their clinical application potential from two key platforms, and addresses the standardization process of CEA detection. This paper highlights the importance of developing rapid and precise methods for CEA analysis in complex matrices and their standardization.
Indexed as
Identifiers
40069381What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.